Related Experiment Video
Updated: Jan 17, 2026
Assessment of the Immunomodulatory Properties of Human Mesenchymal Stem Cells MSCs
Published on: December 24, 2015
Examining the Effects of Quercetin on Phenotypic Characteristics of Human Mesenchymal Stem Cells
Thomas Needy1, David Heinrichs1, Vitali Maldonado1
1Department of Biomedical Engineering, University of Arkansas, 700 W Research Center Boulevard, Fayetteville, AR USA.
Introduction:
A significant obstacle to mesenchymal stem cell (MSC) potency and therapeutic utility is in vitro senescence, an irreversible cessation of replication associated with age-related complications. Senolytic drugs, such as quercetin, may be helpful in selectively culling senescent cells while leaving non-senescent cells unaffected, thereby increasing potency of high-passage MSCs.
Methods:
The phenotypic, genotypic, and immunomodulatory effects of quercetin were assessed using in vitro models. Senescent cells, created through repeated subculturing of MSCs in vitro, and non-senescent cells were treated with 10 μM quercetin, differentiated into osteocytes, adipocytes, and chondrocytes, and analyzed to observe the effect of quercetin.
Results:
Quercetin was not found to be beneficial to MSC function. It did not exhibit a consistent senolytic effect as evidenced by SAβ-gal and live dead staining, hindered proliferation in the short term in some donors, and lowered the expression of osteogenic markers COL1A1 and ALP. Quercetin treatment did not, however, negatively affect adipogenesis, chondrogenesis, or indoleamine 2,3 dioxygenase secretions.
Conclusion:
This study contributes insight into the nature of quercetin and its effects on in vitro MSC culture and function.
Insights
Quercetin did not improve mesenchymal stem cell (MSC) function or consistently eliminate senescent cells. This senolytic drug hindered proliferation and osteogenic markers, offering no therapeutic benefit for MSCs.
Area of Science:
- Stem Cell Biology
- Gerontology
- Pharmacology
Background:
- Mesenchymal stem cells (MSCs) lose potency due to in vitro senescence, limiting their therapeutic use.
- Senolytic drugs, like quercetin, are investigated to remove senescent cells and restore MSC function.
Purpose of the Study:
- To evaluate the senolytic potential and functional effects of quercetin on in vitro cultured mesenchymal stem cells.
Main Methods:
- Senescent and non-senescent MSCs were treated with quercetin (10 μM).
- Cells were analyzed for senescence markers (SAβ-gal, live/dead staining), proliferation, and differentiation into osteocytes, adipocytes, and chondrocytes.
- Gene expression of osteogenic markers (COL1A1, ALP) and indoleamine 2,3 dioxygenase secretion were assessed.
Main Results:
- Quercetin did not consistently reduce senescent cells.
- Short-term proliferation was hindered in some donors.
- Osteogenic differentiation markers (COL1A1, ALP) were reduced.
- Adipogenesis, chondrogenesis, and indoleamine 2,3 dioxygenase secretion were unaffected.
Conclusions:
- Quercetin is not beneficial for mesenchymal stem cell function or senolytic therapy in vitro.
- The drug demonstrated no consistent senolytic effect and negatively impacted osteogenesis.
